Replies to post #231008 on Biotech Values

[DewDiligence]

ABT 2Q20 Results by Business Segment

  
                  %Corp      YoY Growth 
 Segment          Sales   (const currency) 
 Medical devices*  33%       -20% 
 Diagnostics       27%        +7% 
 Nutrition         26%        +3% 
 Drugs†            14%        -1%

COVID-19 testing boosted the diagnostics segment, while the cessation of elective surgical procedures clipped the medical-devices segment.

64% of overall sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.